Advanced Wound Care USA 2024

Advanced Wound Care Summit

The Advanced Wound Care Summit USA Returns July 2024

CHECK OUT OUR SISTER EVENT

ADVANCED WOUND CARE SUMMIT

Boston, USA
10-11 July, 2024

“A perfect conference for everybody interested in this complex topic, a perfect introduction for the novice, an update for the expert and room for exchange, discussions and networking.”

Helene Lecomte, New Product Development Manager, Smith & Nephew

Photo Gallery

HEAR FROM OUR AUDIENCE

The Advanced Wound Care Summit is wound care’s only industry-led forum

It’s a chance for senior executives to address shared challenges around innovative product development, build meaningful partnerships, and sharpen their R&D and commercial strategies. 

Whether an established wound care company, an emerging startup, an SME, a regulator, a payer, or key opinion leader, this event serves your strategic and commercial goals.

To take this chance to uncover how leading figures are leveraging novel clinical trial designs, addressing reimbursement challenges surrounding skin substitute products, progressing next generation diagnostic innovations, and much more. 

OUR PREVIOUS INNOVATION SHOWCASE SELECTION COMMITTEE

Author:

Kris Kieswetter

Global Senior Director, Applied Medical Sciences
3M

Kris Kieswetter

Global Senior Director, Applied Medical Sciences
3M

Author:

Thomas Busby

Vice President
Outcome Capital

Thomas Busby is a Vice President  and has been with Outcome Capital since 2015.  He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches.  Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential. Thomas has been published in leading life science journals Life Science Leader and The Pharma Letter, and also serves on the board of HealthTech Build, a Boston-based digital health innovation group.

 

Prior to his career in life-science investment banking, Thomas pursued his passion for the public service and non-profit sectors working in a variety of leadership and management positions, and at one time held a Massachusetts teaching license.

Thomas completed his MBA at Suffolk University’s Sawyer Business School on full academic scholarship where he was President of the school’s Graduate Business Association and class speaker at graduation. Prior, he completed a BS in Philosophy with Honors from Suffolk’s College of Arts & Sciences. Committed to giving back, Thomas is currently the President of the College of Arts & Sciences Alumni Board of Directors. Thomas is a FINRA Registered Securities Representative holding his Series 79 and 63.

Thomas Busby

Vice President
Outcome Capital

Thomas Busby is a Vice President  and has been with Outcome Capital since 2015.  He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches.  Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential. Thomas has been published in leading life science journals Life Science Leader and The Pharma Letter, and also serves on the board of HealthTech Build, a Boston-based digital health innovation group.

 

Prior to his career in life-science investment banking, Thomas pursued his passion for the public service and non-profit sectors working in a variety of leadership and management positions, and at one time held a Massachusetts teaching license.

Thomas completed his MBA at Suffolk University’s Sawyer Business School on full academic scholarship where he was President of the school’s Graduate Business Association and class speaker at graduation. Prior, he completed a BS in Philosophy with Honors from Suffolk’s College of Arts & Sciences. Committed to giving back, Thomas is currently the President of the College of Arts & Sciences Alumni Board of Directors. Thomas is a FINRA Registered Securities Representative holding his Series 79 and 63.

Author:

Ibraheem Badejo

Senior R&D Director, External Front End Innovation
Johnson & Johnson

Ibraheem (Ib) is Senior R&D Director, External Front End Innovation at Johnson & Johnson Innovation, Boston. He leverages his expertise in smart materials and biomaterials to support the medical device sector.

From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials. Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by J&J in 2005). Prior to joining Closure, he held various positions at Bayer, North Carolina State University, College of Charleston. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University.

During his career, Ib has led teams in the development of commercialized biomaterials based products and new technology / products licensed or acquired.

Ib received his BA degree in chemistry from Avila University.  He received his PhD in Organic chemistry from the University of Toledo, where he was the Robert Whiteford Memorial Scholar for Outstanding Graduate Research and a Petroleum Research Fund Fellow. He is also the recipient of 24 US patents with others pending

Ibraheem Badejo

Senior R&D Director, External Front End Innovation
Johnson & Johnson

Ibraheem (Ib) is Senior R&D Director, External Front End Innovation at Johnson & Johnson Innovation, Boston. He leverages his expertise in smart materials and biomaterials to support the medical device sector.

From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials. Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by J&J in 2005). Prior to joining Closure, he held various positions at Bayer, North Carolina State University, College of Charleston. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University.

During his career, Ib has led teams in the development of commercialized biomaterials based products and new technology / products licensed or acquired.

Ib received his BA degree in chemistry from Avila University.  He received his PhD in Organic chemistry from the University of Toledo, where he was the Robert Whiteford Memorial Scholar for Outstanding Graduate Research and a Petroleum Research Fund Fellow. He is also the recipient of 24 US patents with others pending

Author:

Parth Desai

Principal
Flare Capital Partners

Parth Desai

Principal
Flare Capital Partners

Author:

Artem Trotsyuk

Venture Partner
R42 Group

Artem Trotsyuk

Venture Partner
R42 Group

AUDIENCE BREAKDOWN

10%
Medical Textiles
35%
Multinational Wound Care Companies
15%
Healthcare Professionals + Academics
30%
Start-ups
10%
CMOs/CDMOs

Medical Textiles

Multinational Wound Care Companies

Healthcare Professionals + Academics

Start-ups

CMOs/CDMOs

PREVIOUS SPEAKERS

 

Kris Kieswetter

Global Senior Director, Applied Medical Sciences
3M

Kris Kieswetter

Global Senior Director, Applied Medical Sciences
3M

Kris Kieswetter

Global Senior Director, Applied Medical Sciences
3M
 

Ibraheem Badejo

Senior R&D Director, External Front End Innovation
Johnson & Johnson

Ibraheem (Ib) is Senior R&D Director, External Front End Innovation at Johnson & Johnson Innovation, Boston. He leverages his expertise in smart materials and biomaterials to support the medical device sector.

Ibraheem Badejo

Senior R&D Director, External Front End Innovation
Johnson & Johnson

Ibraheem Badejo

Senior R&D Director, External Front End Innovation
Johnson & Johnson

Ibraheem (Ib) is Senior R&D Director, External Front End Innovation at Johnson & Johnson Innovation, Boston. He leverages his expertise in smart materials and biomaterials to support the medical device sector.

From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials. Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by J&J in 2005). Prior to joining Closure, he held various positions at Bayer, North Carolina State University, College of Charleston. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University.

During his career, Ib has led teams in the development of commercialized biomaterials based products and new technology / products licensed or acquired.

Ib received his BA degree in chemistry from Avila University.  He received his PhD in Organic chemistry from the University of Toledo, where he was the Robert Whiteford Memorial Scholar for Outstanding Graduate Research and a Petroleum Research Fund Fellow. He is also the recipient of 24 US patents with others pending

 

Elizabeth Hamacher

Vice President, Clinical Services and Support
Podimetrics

Elizabeth is a solutions-driven health care executive with demonstrated success in leading both clinical and administrative growth across multiple health care settings. As Vice President of Care Management, she is responsible for scaling Podimetrics’ work to efficiently and effectively serve more patients.

Elizabeth Hamacher

Vice President, Clinical Services and Support
Podimetrics

Elizabeth Hamacher

Vice President, Clinical Services and Support
Podimetrics

Elizabeth is a solutions-driven health care executive with demonstrated success in leading both clinical and administrative growth across multiple health care settings. As Vice President of Care Management, she is responsible for scaling Podimetrics’ work to efficiently and effectively serve more patients. Elizabeth has held clinical leadership roles at Consumer Medical, Beth Israel Lahey Health, Coastal Medical, Cape Cod Healthcare Physician Hospital Organization, and Emerald Physician Services LLC, leading strategic planning, leadership development, operations, and quality improvement efforts. She holds a Master’s degree in Healthcare Leadership from Brown University, a Bachelor of Science in nursing from Massachusetts General Hospital Institute of Health Professions, and a Bachelor of Science in Mathematical Sciences from Worcester Polytechnic Institute.

 

 

Julie Morabito

Assistant Director
FDA

Assistant Director, Division of Infection Control and Plastic and Reconstructive Surgery at FDA’s Center for Devices and Radiological Health (CDRH). (Plastic Surgery Skin and Wound Devices Team).

Julie Morabito

Assistant Director
FDA

Julie Morabito

Assistant Director
FDA

Assistant Director, Division of Infection Control and Plastic and Reconstructive Surgery at FDA’s Center for Devices and Radiological Health (CDRH). (Plastic Surgery Skin and Wound Devices Team).

 

Monique Rennie

Global Director, Medical Affairs, Wound Care
Mölnlycke

Monique Rennie

Global Director, Medical Affairs, Wound Care
Mölnlycke

Monique Rennie

Global Director, Medical Affairs, Wound Care
Mölnlycke
 

Ira Herman

Senior Director, Biological Sciences
Precision Healing

Ira Herman

Senior Director, Biological Sciences
Precision Healing

Ira Herman

Senior Director, Biological Sciences
Precision Healing
 

Katherine Piette

Chief Executive Officer
Corstrata

Katherine Piette

Chief Executive Officer
Corstrata

Katherine Piette

Chief Executive Officer
Corstrata
 

Mike Griffiths

Chief Executive Officer & Medical Director
Advanced Oxygen Therapy

Mike Griffiths

Chief Executive Officer & Medical Director
Advanced Oxygen Therapy

Mike Griffiths

Chief Executive Officer & Medical Director
Advanced Oxygen Therapy
 

Mitch Sanders

Chief Executive Officer
ProDevLabs

Mitch Sanders

Chief Executive Officer
ProDevLabs

Mitch Sanders

Chief Executive Officer
ProDevLabs
 

Davide Vigano

Co-founder and CEO
Sensoria Health

Sensoria designs, develops and produces bio-sensing wearable garments. The vision of the company is that the Garment itself will become the next ultra-personal, mobile computer. Davide is a former Microsoft partner level executive with over 25 years of sales, marketing and extensive product management experience. As an intern he started the international localization group for MacWorks and MacOffice in 1987. More recently, he served as General Manager of the Health Solutions Group where he was in charge of marketing and product strategy for both HealthVault and the Amalga product line.

Davide Vigano

Co-founder and CEO
Sensoria Health

Davide Vigano

Co-founder and CEO
Sensoria Health

Sensoria designs, develops and produces bio-sensing wearable garments. The vision of the company is that the Garment itself will become the next ultra-personal, mobile computer. Davide is a former Microsoft partner level executive with over 25 years of sales, marketing and extensive product management experience. As an intern he started the international localization group for MacWorks and MacOffice in 1987. More recently, he served as General Manager of the Health Solutions Group where he was in charge of marketing and product strategy for both HealthVault and the Amalga product line. He acted as Vice President of the Worldwide SMSP Medium Business division which he grew 18% YOY to over $14B. Davide also managed the Italian Marketing, Business and Enterprise operations for five years and brought it to number one in the world for contribution margin, 6th largest Microsoft subsidiary in the world by revenues.

 

Parth Desai

Principal
Flare Capital Partners

Parth Desai

Principal
Flare Capital Partners

Parth Desai

Principal
Flare Capital Partners
 

Chris Rao

SVP Clinical Operations
Alira Health

Chris Rao

SVP Clinical Operations
Alira Health

Chris Rao

SVP Clinical Operations
Alira Health
 

Thomas Serena

Founder & CEO
SerenaGroup

Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, is a Phi Beta Kappa graduate of The College of William and Mary and Penn State Medical School.

Thomas Serena

Founder & CEO
SerenaGroup

Thomas Serena

Founder & CEO
SerenaGroup

Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, is a Phi Beta Kappa graduate of The College of William and Mary and Penn State Medical School.

To date he has opened and operates wound care centers across the United Sates and globally. Dr. Serena has been the lead or Principal investigator in over 100 clinical trials, including gene therapy for critical limb ischemia, antimicrobial dressings, growth factors, topical and parenteral antibiotics and CTP therapy. He founded the first wound healing cooperative research group that produced more than 12 manuscripts in 2016 alone. In 2011 he developed a diagnostic technique that now bears his name (The Serena Technique©). He holds numerous patents on wound care devices and dressings.

He is recognized internationally as an expert in the field of wound healing: He has more than 200 published papers and has given more than 1000 invited lectures throughout the world. He has published three medical textbooks and authored numerous book chapters. He has been a member of the Board of Directors of the Wound Healing Society and served two terms on the board of the Association for the Advancement of Wound Care (AAWC) and is now the President-Elect. He has also been Vice-President of the American College of Hyperbaric Medicine and President of the American Professional Wound Care Association.

Dr. Serena has done extensive medical relief work with Health Volunteers Overseas and served as chairman of the AAWC Global Volunteers/HVO Steering Committee until 2016. In 2016 in partnership with HEAL Foundation he opened a wound clinic in Ho Chi Minh, Vietnam. Outside of wound healing, he consulted for the government of Rwanda on AIDS prevention research.

 

Nikolai Sopko

Chief Scientific Officer and VP of R&D
PolarityTE, Inc.

Dr. Nikolai Sopko obtained his MD with honors from Case Western Reserve University and PhD in stem cell biology at the Cleveland Clinic as a graduate of the National Institutes of Health Medical Scientist Training Program. He completed his surgical training at the Johns Hopkins James Buchanan Brady Urologic Institute as a Physician Scientist Scholar where he focused on regenerative reconstruction, tissue engineering, gene therapy, transplant modulation and tumor biology. He has over 60 published peer-reviewed articles and book chapters and is a speaker on regenerative medicine. Dr.

Nikolai Sopko

Chief Scientific Officer and VP of R&D
PolarityTE, Inc.

Nikolai Sopko

Chief Scientific Officer and VP of R&D
PolarityTE, Inc.

Dr. Nikolai Sopko obtained his MD with honors from Case Western Reserve University and PhD in stem cell biology at the Cleveland Clinic as a graduate of the National Institutes of Health Medical Scientist Training Program. He completed his surgical training at the Johns Hopkins James Buchanan Brady Urologic Institute as a Physician Scientist Scholar where he focused on regenerative reconstruction, tissue engineering, gene therapy, transplant modulation and tumor biology. He has over 60 published peer-reviewed articles and book chapters and is a speaker on regenerative medicine. Dr. Sopko is currently the Chief Scientific Officer and Vice President of Research and Development of PolarityTE where he applies his passion for patient care and basic science 

 

Kenny Carberry

Vice President of Business Development
Alira Health

Kenny leads business development efforts and initiatives for early-stage healthcare companies. His background covers a wide array of indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle from generating a comprehensive strategy through executing a successful trial.

Kenny Carberry

Vice President of Business Development
Alira Health

Kenny Carberry

Vice President of Business Development
Alira Health

Kenny leads business development efforts and initiatives for early-stage healthcare companies. His background covers a wide array of indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle from generating a comprehensive strategy through executing a successful trial.

 

David Alper

Board Adviser
American Diabetes Association Amputation Prevention Alliance

David Alper

Board Adviser
American Diabetes Association Amputation Prevention Alliance

David Alper

Board Adviser
American Diabetes Association Amputation Prevention Alliance
 

Jens Kirsch

Chief Executive Officer
Terraplasma Medical GMBH

Jens Kirsch

Chief Executive Officer
Terraplasma Medical GMBH

Jens Kirsch

Chief Executive Officer
Terraplasma Medical GMBH
 

Windy Cole

Global Medical Affairs Director
NATROX® Wound Care

Windy Cole

Global Medical Affairs Director
NATROX® Wound Care

Windy Cole

Global Medical Affairs Director
NATROX® Wound Care
 

Anthony Kerr

Managing Director
Journal of Wound Care

Anthony Kerr

Managing Director
Journal of Wound Care

Anthony Kerr

Managing Director
Journal of Wound Care
 

Tim Ganey

Chief Scientific Officer
VIVEX Biologics

Tim Ganey

Chief Scientific Officer
VIVEX Biologics

Tim Ganey

Chief Scientific Officer
VIVEX Biologics
 

Dan King

Director of Marketing
Polynovo

Dan King

Director of Marketing
Polynovo

Dan King

Director of Marketing
Polynovo
 

Melissa Bailey

VP of Sales & Marketing
Swift Medical

Melissa Bailey

VP of Sales & Marketing
Swift Medical

Melissa Bailey

VP of Sales & Marketing
Swift Medical
 

Alan Sage

Chief Executive Officer
Vaparox

Alan Sage

Chief Executive Officer
Vaparox

Alan Sage

Chief Executive Officer
Vaparox
 

Arnie Andersen

VP of Post Acute Care
Gentell

Arnie Andersen

VP of Post Acute Care
Gentell

Arnie Andersen

VP of Post Acute Care
Gentell
 

Javier Guirola

Director of Medical Affairs
Polynovo

Javier Guirola

Director of Medical Affairs
Polynovo

Javier Guirola

Director of Medical Affairs
Polynovo
 

Susan Paquette

Vice President and General Manager, Wound
SmartTRAK

Susan Paquette

Vice President and General Manager, Wound
SmartTRAK

Susan Paquette

Vice President and General Manager, Wound
SmartTRAK
 

Mary McGovern

Managing Director
Adtec Healthcare Limited

Mary McGovern

Managing Director
Adtec Healthcare Limited

Mary McGovern

Managing Director
Adtec Healthcare Limited
 

Kyle Quinn

Associate Professor
University of Arkansas

Kyle Quinn

Associate Professor
University of Arkansas

Kyle Quinn

Associate Professor
University of Arkansas
 

Sameer Sonkusale

Professor
Tufts University

Sameer Sonkusale

Professor
Tufts University

Sameer Sonkusale

Professor
Tufts University
 

Molly Carroll

Senior Scientist
Precision Healing

Molly Carroll

Senior Scientist
Precision Healing

Molly Carroll

Senior Scientist
Precision Healing

2024 PARTNERS

EXHIBITOR

Partner with us

Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.
To discuss your objectives and partnership opportunities please contact [email protected]

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

RESOURCES

Download Resource

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us